Page last updated: 2024-08-16

terfenadine and glycoprotein e2, hepatitis c virus

terfenadine has been researched along with glycoprotein e2, hepatitis c virus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, B; Bartenschlager, R; Hartmann, RW; Holzer, M; Kattner, L; Kaul, A; Klein, CD; Kronenberger, B; Ziegler, S1

Other Studies

1 other study(ies) available for terfenadine and glycoprotein e2, hepatitis c virus

ArticleYear
Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization.
    Molecules (Basel, Switzerland), 2008, May-07, Volume: 13, Issue:5

    Topics: Acylation; Antibodies, Viral; Antigens, CD; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Neutralization Tests; Protein Binding; Structure-Activity Relationship; Terfenadine; Tetraspanin 28; Viral Envelope Proteins; Virion

2008